CBD News Update: October Edition

CBD News

Here is the round up of news and highlights related to CBD and Cannabis during the past month.

Nation’s Largest Arthritis Advocacy Group Releases CBD Guidelines

The Arthritis Foundation, the largest advocacy group in the United States for people with arthritis, is helping its members boost their knowledge of CBD, with a new article titled  CBD Guidance for Adults with Arthritis. In a recent, survey, 79% of members from the Arthritis Foundation were either using or interested in using CBD. The article demonstrates how the foundation is now recognizing CBD’s popular use for chronic pain and arthritis.

National Institutes of Health Doles Out $3 Million in CBD Research Grants

The National Insitute of Health awarded nine research grants totaling approximately $3 million to investigate the potential pain-relieving properties and mechanisms of  the diverse phytochemicals in cannabis, including both minor cannabinoids and terpenes. This is significant for CBD research, as some feel the science for CBD lags behind public interest and use.

New Marijuana 1-to-3 Act Would Reclassify Cannabis Under Federal Law

Rep. Greg Steube (R-FL) introduced a legislation titled Marijuana 1-to-3 Act. This bill would require the attorney general to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, with the aim of increasing research on the drug’s effects. Placing cannabis to Schedule III would have implications for marijuana businesses, who are currently ineligible for federal tax deductions.

Growing Support for Legalizing Marijuana in Colombia

Colombia’s legislature will soon take up a bill to legalize and regulate the production and consumption of marijuana for adults. Sen. Gustavo Bolivar of the opposition Colombia Humana party is filing this bill with the hope of curtailing crime and supporting a public health-focused approach to drug policy. If the bill passes, Colombia will join Mexico, where lawmakers are readying legislation to legalize marijuana for adult use.

Leave a Comment

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Your email address will not be published. Required fields are marked *